Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
171
currently held
Exits tracked
127
hand-checked
Sectors covered
1
across the portfolio
Countries covered
31
from every market
241 companies matching · Page 1 of 5
AMW
SHS VI
GermanySector
Pharma
InvestorSHS Gesellschaft für Beteiligungsmanagement
Entry
2014
Hold
12yr
Owners
4
Galderma
Ardian Co-Investment Fund V
SwitzerlandSector
Pharma
InvestorArdian
Entry
2019
Hold
7yr
Owners
3
STADA Arzneimittel
CM-CIC Debt Fund 2
GermanySector
Pharma
InvestorCIC Private Debt
Entry
2017
Hold
9yr
Owners
3
Omnicare
Equistone Partners Europe Fund VI
USASector
Pharma
InvestorEquistone Partners Europe
Entry
2019
Hold
7yr
Owners
2
Exit
2026
Allderma
3iM Equity Partners
SwedenSector
Pharma
Investor3iM
Entry
2020
Hold
6yr
Exit
2026
Ceva
NiXEN II
FranceSector
Pharma
InvestorNiXEN
Entry
1999
Hold
16yr
Owners
15
Olyos
LFPI Capital
FranceSector
Pharma
InvestorLFPI GESTION
Entry
2018
Hold
7yr
Owners
3
Dec Group
capiton VI
SwitzerlandSector
Pharma
Investorcapiton
Entry
2020
Hold
5yr
Owners
2
HTBA
Miura Fund III
SpainSector
Pharma
InvestorMiura Partners
Entry
2019
Hold
6yr
Owners
2
Nuzoa
PAI Mid-Market Fund
SpainSector
Pharma
InvestorPAI Partners
Entry
2020
Hold
5yr
Owners
2
Neopharmed Gentili
NB Renaissance Fund III
ItalySector
Pharma
InvestorRenaissance Partners
Entry
2018
Hold
7yr
Owners
3
DMX Pharma
Alto Capital IV
ItalySector
Pharma
InvestorAlto Partners SGR
Entry
2022
Hold
3yr
Exit
2025
Provell Pharmaceuticals
Flerie Invest
United StatesSector
Pharma
InvestorFlerie
Entry
2013
Hold
12yr
Exit
2025
Sifi
21 Investimenti II
ItalySector
Pharma
Investor21 Invest
Entry
2010
Hold
15yr
Exit
2025
Cinclus Pharma
Claret European Growth Capital Fund IV
SwedenSector
Pharma
InvestorClaret Capital Partners
Entry
2022
Hold
2yr
Owners
3
ProductLife Group
21 Invest PLG Continuation Fund
FranceSector
Pharma
Investor21 Invest
Entry
2017
Hold
7yr
Owners
3
Aenova
BC European Capital IX
UKSector
Pharma
InvestorBC Partners
Entry
2005
Hold
12yr
Owners
2
Exit
2024
Synerlab
Crédit Mutuel Equity
FranceSector
Pharma
InvestorCrédit Mutuel Equity
Entry
2007
Hold
11yr
Owners
4
Salfarm
Polaris Private Equity V
DenmarkSector
Pharma
InvestorPolaris
Entry
2020
Hold
4yr
Owners
2
APONTIS PHARMA
Paragon Fund II
GermanySector
Pharma
InvestorParagon Partners
Entry
2018
Hold
6yr
Exit
2024
Content Group
Aksia Capital IV
ItalySector
Pharma
InvestorAksia SGR
Entry
2016
Hold
8yr
Exit
2024
Salpharm Holding ApS
Industri Udvikling V
DenmarkSector
Pharma
InvestorIndustri Udvikling
Entry
2020
Hold
4yr
Exit
2024
Unither
Parquest Capital 2
FranceSector
Pharma
InvestorParquest Capital
Entry
1993
Hold
33yr
Owners
5
Natac Group
Stellum Food & Tech I
SpainSector
Pharma
InvestorStellum Capital
Entry
2021
Hold
3yr
Owners
2
Acer Therapeutics
TVM Life Science Ventures
United StatesSector
Pharma
InvestorTVM Capital Life Science
Entry
2015
Hold
8yr
Exit
2023
Archimica
LIVIA Corporate Development
ItalySector
Pharma
InvestorLIVIA Group
Entry
2019
Hold
4yr
Exit
2023
Diater
Fondo Nazca Small Cap I
SpainSector
Pharma
InvestorNazca Capital
Entry
2019
Hold
4yr
Exit
2023
EffRx Pharmaceuticals
Sobera Capital Fund IV
SwitzerlandSector
Pharma
InvestorSobera Capital
Entry
2018
Hold
5yr
Exit
2023
Labomar
Charterhouse Capital Partners XI
ItalySector
Pharma
InvestorCharterhouse Capital Partners
Entry
2020
Hold
3yr
Owners
2
Acino
Ardian Co-Investment Fund III
SwitzerlandSector
Pharma
InvestorArdian
Entry
2013
Hold
9yr
Owners
2
Exit
2022
CordenPharma
Astorg Mid-Cap
FranceSector
Pharma
InvestorAstorg
Entry
2006
Hold
16yr
Owners
2
Pharmalex
Auctus III
GermanySector
Pharma
InvestorAuctus Capital Partners
Entry
2014
Hold
8yr
Exit
2022
Kedrion
Permira VII
ItalySector
Pharma
InvestorPermira
Entry
2003
Hold
10yr
Owners
4
Doc Generici
Mérieux Participations 3
FranceSector
Pharma
InvestorMerieux Equity Partners
Entry
2013
Hold
3yr
Owners
3
Exit
2022
IPS Specials
Mezzanine II
UKSector
Pharma
InvestorBeechbrook Capital
Entry
2010
Hold
12yr
Owners
2
The Ritedose Corporation
Novo Holdings Seed Investments
United StatesSector
Pharma
InvestorNovo Holdings
Entry
2017
Hold
5yr
Owners
2
DOC Generici (ICG)
ICG Europe Fund VII
ItalySector
Pharma
InvestorICG
Entry
2019
Hold
3yr
Exit
2022
Mipharm
Mandarin Capital Partners II
ItalySector
Pharma
InvestorMindful Capital Partners
Entry
2016
Hold
6yr
Exit
2022
Arcinova
BGF
UKSector
Pharma
InvestorBGF
Entry
2018
Hold
3yr
Exit
2021
Curapath
Columbus Innvierte Life Science Fund I
SpainSector
Pharma
InvestorColumbus Venture Partners
Entry
2017
Hold
4yr
Exit
2021
HRA Pharma
Astorg VI
FranceSector
Pharma
InvestorAstorg
Entry
2016
Hold
5yr
Exit
2021
iNova
Carlyle Europe Technology Partners IV
Australia
Sector
Pharma
InvestorThe Carlyle Group
Entry
–
Exit
2021
Sygnature Discovery
Five Arrows Principal Investments
UKSector
Pharma
InvestorFive Arrows Managers
Entry
2019
Hold
5yr
Owners
3
Cooper
CVC Capital Partners Fund VII
UKSector
Pharma
InvestorCVC Capital Partners
Entry
2015
Hold
6yr
Owners
2
Pharmathen
Partners Group Direct Equity IV
Greece
Sector
Pharma
InvestorPartners Group
Entry
2015
Hold
6yr
Owners
2
Fertin Pharma
EQT Mid Market Europe
DenmarkSector
Pharma
InvestorEQT
Entry
2017
Hold
4yr
Exit
2021
Idifarma
Sodena Direct
SpainSector
Pharma
InvestorSodena
Entry
2006
Hold
15yr
Exit
2021
Pharmaceutical Product Development, Inc. (PPD)
Carlyle Partners V, L.P.
USASector
Pharma
InvestorThe Carlyle Group
Entry
–
Exit
2021
Sunsho Pharmaceutical Co., Ltd.
The Carlyle Group Portfolio
Japan
Sector
Pharma
InvestorThe Carlyle Group
Entry
–
Exit
2021
Xeris Biopharma Holdings, Inc (Strongbridge)
HealthCap VI
United StatesSector
Pharma
InvestorHealthCap
Entry
2014
Hold
7yr
Exit
2021